Navigation Links
Lori Silver Joins Decision Resources, Inc. as General Counsel
Date:7/24/2008

Formerly of Harvard University's Office of General Counsel, Attorney Will

be Responsible for All Legal Aspects of the Company

WALTHAM, Mass., July 24 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, announced today that Lori Silver has joined the company as General Counsel, responsible for all legal aspects of the company. Ms. Silver comes to Decision Resources with an impressive array of relevant experience, including five years at the Office of the General Counsel of Harvard University, handling litigation, contracts, intellectual property, computer and internet issues and international operations.

Ms. Silver received a B.A. in Political Science from Stanford University and a J.D. from Harvard Law School. Ms. Silver has chaired the Boston Bar Association's Arts, Entertainment & Sports Law Committee and was named one the Boston area's "Rising Star" lawyers by Boston Magazine in 2006 and 2007.

Ms. Silver is responsible for managing all legal issues related to Decision Resources, Inc.'s business, including commercial agreements, intellectual property, employment, licensing and acquisitions.

"We are very excited that Lori has joined our team," said Peter Hoenigsberg, CEO of Decision Resources. "As Decision Resources, Inc. continues to implement an aggressive growth strategy -- both organically and through acquisitions-Lori will be instrumental in helping us achieve our business expansion goals, owing to her wide-range of impressive legal expertise, especially in the areas of intellectual property protection and compliance in general."

About Decision Resources, Inc.

Decision Resources, Inc. is a portfolio of companies that offer best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed, knowledgeable decisions. Decision Resources,
'/>"/>

SOURCE Decision Resources, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Paramount Health Care Company Partners With Silverchair Learning Systems
2. Silver-Coated Endotracheal Tubes Cut Down on Infections
3. RealAge Wins Silver PhAME Award
4. Prime Clinical Systems Celebrates Silver Anniversary
5. Resource Systems and Silverchair Learning Systems Launch CareTracker Online Training Module
6. A new way to fight cancer: the silver shield
7. HealthMEDX Partners With Silverchair Learning Systems
8. Seal Shield Introduces New Silver Seal Washable, Antimicrobial Mouse at HiMSS Healthcare Symposium
9. Seal Shield Ships New SILVER SEAL(TM) Washable, Antimicrobial Keyboard
10. Alexian Brothers Hospital Network Receives American Stroke Associations Get with the Guidelines Silver Achievement Award
11. Epilepsy.com Wins Silver for Best Patient Care/Disease Management Website at the 2007 eHealthcare Leadership Awards - Honored at Healthcare Internet Conference in Las Vegas
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine Technology:Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 2Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 3Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 4Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 5Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 6Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 2Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 3Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 4Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 5Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 6Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 7